Eii Capital Management Inc increased its stake in Amag Pharmaceuticals Inc Com (AMAG) by 41.48% based on its latest 2017Q3 regulatory filing with the SEC. Eii Capital Management Inc bought 35,090 shares as the company’s stock declined 21.74% while stock markets rallied. The institutional investor held 119,690 shares of the health care company at the end of 2017Q3, valued at $2.21 million, up from 84,600 at the end of the previous reported quarter. Eii Capital Management Inc who had been investing in Amag Pharmaceuticals Inc Com for a number of months, seems to be bullish on the $703.95 million market cap company. The stock increased 1.27% or $0.25 during the last trading session, reaching $19.9. About 871,706 shares traded. AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) has risen 3.00% since February 27, 2017 and is uptrending. It has underperformed by 13.70% the S&P500.
Paul Glazer decreased its stake in Straight Path Communicatns I (STRP) by 6.56% based on its latest 2017Q3 regulatory filing with the SEC. Glazer Capital Llc sold 15,446 shares as the company’s stock rose 414.53% with the market. The hedge fund run by Paul Glazer held 220,078 shares of the telecommunications equipment company at the end of 2017Q3, valued at $39.76M, down from 235,524 at the end of the previous reported quarter. Glazer Capital Llc who had been investing in Straight Path Communicatns I for a number of months, seems to be less bullish one the $2.37B market cap company. The stock increased 1.33% or $2.44 during the last trading session, reaching $185.87. About 342,257 shares traded or 105.38% up from the average. Straight Path Communications Inc. (NYSEMKT:STRP) has risen 435.39% since February 27, 2017 and is uptrending. It has outperformed by 418.69% the S&P500.
Among 14 analysts covering AMAG Pharmaceuticals (NASDAQ:AMAG), 4 have Buy rating, 1 Sell and 9 Hold. Therefore 29% are positive. AMAG Pharmaceuticals had 41 analyst reports since August 18, 2015 according to SRatingsIntel. The firm has “Buy” rating by Jefferies given on Thursday, August 11. The firm has “Overweight” rating by Morgan Stanley given on Friday, November 3. The stock of AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) has “Hold” rating given on Thursday, November 19 by Deutsche Bank. The rating was maintained by Leerink Swann with “Outperform” on Wednesday, May 4. Deutsche Bank reinitiated AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) rating on Thursday, September 3. Deutsche Bank has “Hold” rating and $71.0 target. Janney Capital upgraded the shares of AMAG in report on Thursday, February 15 to “Buy” rating. Deutsche Bank maintained the shares of AMAG in report on Wednesday, November 4 with “Hold” rating. On Thursday, January 18 the stock rating was maintained by Piper Jaffray with “Hold”. The rating was downgraded by Raymond James to “Market Perform” on Wednesday, May 4. Jefferies maintained the stock with “Buy” rating in Friday, November 3 report.
Investors sentiment increased to 1.44 in Q3 2017. Its up 0.35, from 1.09 in 2017Q2. It is positive, as 21 investors sold AMAG shares while 43 reduced holdings. 35 funds opened positions while 57 raised stakes. 39.98 million shares or 4.47% less from 41.85 million shares in 2017Q2 were reported. Barclays Public Ltd Company, a United Kingdom-based fund reported 5,532 shares. Nationwide Fund Advsr accumulated 50,978 shares. Credit Suisse Ag accumulated 50,748 shares or 0% of the stock. Livforsakringsbolaget Skandia Omsesidigt accumulated 49,600 shares or 0.08% of the stock. Parametric Portfolio Assoc Ltd Llc reported 284,391 shares. Her Majesty The Queen In Right Of The Province Of Alberta As Represented By Alberta Inv Mgmt holds 0.01% or 67,600 shares in its portfolio. Assetmark holds 0% or 386 shares in its portfolio. Panagora Asset Management Inc invested in 0.02% or 220,925 shares. Meeder Asset Management reported 0% stake. Qs Invsts Limited Company has invested 0.02% in AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG). Dekabank Deutsche Girozentrale invested 0% of its portfolio in AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG). Dupont Cap Mgmt owns 19,731 shares for 0.01% of their portfolio. Ameriprise Inc has 0% invested in AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG). Camber Capital Mgmt Ltd Limited Liability Company invested in 3.1% or 2.65M shares. Grp One Trading Lp holds 0% or 10,326 shares.
Eii Capital Management Inc, which manages about $5.06B and $267.41 million US Long portfolio, decreased its stake in Essex Ppty Tr Inc Com (NYSE:ESS) by 18,725 shares to 15,560 shares, valued at $3.95 million in 2017Q3, according to the filing. It also reduced its holding in Store Cap Corp Com (NYSE:STOR) by 246,100 shares in the quarter, leaving it with 60,400 shares, and cut its stake in Ggp Inc Com.
Since October 13, 2017, it had 0 buys, and 9 insider sales for $12.57 million activity. 3,994 shares valued at $724,780 were sold by BREAU DAVID L on Thursday, October 19. RAND JONATHAN had sold 4,513 shares worth $819,148. $1.45 million worth of Straight Path Communications Inc. (NYSEAMERICAN:STRP) was sold by WELD WILLIAM F. ZEIDMAN FRED S also sold $2.72 million worth of Straight Path Communications Inc. (NYSEAMERICAN:STRP) shares. On Wednesday, December 20 TODD K CHRIS sold $1.40 million worth of Straight Path Communications Inc. (NYSEAMERICAN:STRP) or 7,700 shares.
Glazer Capital Llc, which manages about $836.60 million and $1.04B US Long portfolio, upped its stake in Parexel Intl Corp (NASDAQ:PRXL) by 426,988 shares to 1.23M shares, valued at $108.72 million in 2017Q3, according to the filing. It also increased its holding in Avista Healthcare Pub Acq Co by 1.49M shares in the quarter, for a total of 2.70 million shares, and has risen its stake in First Potomac Rlty Tr (NYSE:FPO).
Investors sentiment decreased to 1.73 in 2017 Q3. Its down 0.17, from 1.9 in 2017Q2. It dropped, as 16 investors sold STRP shares while 24 reduced holdings. 22 funds opened positions while 47 raised stakes. 6.64 million shares or 11.93% more from 5.93 million shares in 2017Q2 were reported. Equitec Proprietary Mkts reported 0.94% of its portfolio in Straight Path Communications Inc. (NYSEAMERICAN:STRP). Nomura Holdings reported 4,500 shares stake. Vanguard Group reported 0.01% in Straight Path Communications Inc. (NYSEAMERICAN:STRP). Geode Cap Mgmt Ltd accumulated 68,395 shares. Bradley Foster Sargent Ct owns 4,910 shares. P Schoenfeld Asset Management Lp invested in 1.47% or 131,735 shares. Adage Cap Ptnrs Group Limited Liability Corporation invested 0.01% in Straight Path Communications Inc. (NYSEAMERICAN:STRP). Wells Fargo And Mn holds 96,429 shares. Citadel Advsr Lc invested in 36,501 shares. State Street stated it has 0% of its portfolio in Straight Path Communications Inc. (NYSEAMERICAN:STRP). Schwab Charles invested in 0.01% or 37,467 shares. Glazer Capital Limited has 220,078 shares for 3.81% of their portfolio. Pentwater Management Ltd Partnership reported 0.81% of its portfolio in Straight Path Communications Inc. (NYSEAMERICAN:STRP). Manufacturers Life Ins The invested in 7,407 shares. 6,000 are held by Strs Ohio.
The post Amag Pharmaceuticals Com (AMAG) Position Boosted by Eii Capital Management Inc; As Straight Path Communicatns I (STRP) Shares Rose, Glazer Capital Lowered Holding appeared first on Stock Market News | HillCountryTimes | Get it Today.
from
https://www.hillcountrytimes.com/2018/02/27/amag-pharmaceuticals-com-amag-position-boosted-by-eii-capital-management-inc-as-straight-path-communicatns-i-strp-shares-rose-glazer-capital-lowered-holding/
No comments:
Post a Comment